Skip to main navigation Skip to search Skip to main content

Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis b: Results of 192-week phase 3 trial

  • Do Seon Song
  • , Won Kim
  • , Sang Hoon Ahn
  • , Hyung Joon Yim
  • , Jae Young Jang
  • , Young Oh Kweon
  • , Yong Kyun Cho
  • , Yoon Jun Kim
  • , Gun Young Hong
  • , Dong Joon Kim
  • , Young Kul Jung
  • , Joo Hyun Sohn
  • , Jin Woo Lee
  • , Sung Jae Park
  • , Byung Seok Lee
  • , Ju Hyun Kim
  • , Hong Soo Kim
  • , Seung Kew Yoon
  • , Moon Young Kim
  • , Kwan Sik Lee
  • Young Suk Lim, Wan Sik Lee, Jin Mo Yang, Kyun Hwan Kim, Kwang Hyub Han, Soon Ho Um
  • Seoul National University
  • Yonsei University
  • Korea University
  • Soonchunhyang University
  • Kyungpook National University
  • Kangbuk Samsung Hospital
  • Kwangju Christian Hospital
  • Hallym University
  • Hanyang University
  • Inha University
  • Inje University
  • Chungnam National University
  • Gachon University
  • Yonsei University Mirae Campus
  • University of Ulsan
  • Chonnam National University
  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis b: Results of 192-week phase 3 trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science